Stem Cell treatment in Diabetes


Patients with diabetes mellitus have a great deal to gain from stem cell treatments. The phases of development and transcription factors involved in this process have been identified through research on the capacity of human embryonic stem cells to differentiate into islet cells. However, ethical questions and the potential for teratoma formation restrict the clinical applications of human embryonic stem cells. Alternative stem cell treatments, such as induced pluripotent stem cells, umbilical cord stem cells, and mesenchymal stem cells derived from bone marrow, have consequently attracted a great deal of research. Recent developments in stem cell therapy could make this a viable diabetes remedy in the near future.

    Related Conference of Stem Cell treatment in Diabetes

    February 24-25, 2025

    34th European Diabetes Congress

    London, UK
    March 10-11, 2025

    4th Global Summit on Physiology and Metabolism of Thyroid

    Singapore City, Singapore
    March 17-18, 2025

    5th European Endocrinology and Diabetes Congress

    Paris, France
    April 10-11, 2025

    5th World Congress on Endocrine and Diabetes

    Dubai, UAE
    April 10-11, 2025

    4th International Summit on Hormonal Disorders

    Dubai, UAE
    May 19-20, 2025

    6th World Summit on Diabetes

    Rome, Italy
    June 04-05, 2025

    4th World Congress on Diabetes and Pediatric Endocrinology

    Edinburgh, Scotland
    July 29-30, 2025

    15th World Congress on Endocrinology and Diabetes

    Aix-en-Provence, France
    September 08-09, 2025

    3rd World congress and Expo on Diabetes

    Frankfurt, Germany
    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Aix-en-Provence, France

    Stem Cell treatment in Diabetes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in